论文部分内容阅读
越来越多的实验室及临床资料表明,再生障碍性贫血(简称再障)不是单一性的疾病,而是包含一组伴发骨髓增生不良的全血细胞减少的多种疾病。由于对其病理生理缺乏确切的了解,导致各种互不相关的治疗途径。迄今,除了支持治疗以外,多数再障患者是用雄性激素或骨髓移植来治疗的。最近,免疫抑制疗法对某些患者看来有些疗效。雄性素通过刺激产生红细胞生成素和激发
More and more laboratory and clinical data show that aplastic anemia (referred to as aplastic anemia) is not a single disease, but contains a group with myelodysplastic pancytopenia of various diseases. The lack of an exact understanding of their pathophysiology has led to a variety of unrelated treatments. To date, most patients with aplastic anemia have been treated with androgen or bone marrow transplantation in addition to supportive care. Recently, immunosuppressive therapy appears to have some effect in some patients. Androgens stimulate erythropoietin production and stimulation